Eli Lilly misses revenue forecast

April 24 (Reuters) - U.S. drugmaker Eli Lilly and Co on Thursday reported lower than expected revenue, hurt by plunging sales of its Cymbalta depression drug, which is now facing generic competition.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.